T2D
Clinical trials for T2D explained in plain language.
Never miss a new study
Get alerted when new T2D trials appear
Sign up with your email to follow new studies for T2D, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weight-Loss drug investigated as potential kidney protector
Disease control OngoingThis study is investigating whether the medication tirzepatide, which is approved for weight loss and diabetes, can improve kidney health in people who are overweight or obese and have chronic kidney disease. Researchers will use special MRI scans to see if the drug increases oxy…
Matched conditions: T2D
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Doctors check how many diabetics have hidden liver damage
Knowledge-focused OngoingThis study aims to find out how common fatty liver disease is in people who have type 2 diabetes. Researchers at a hospital in Belgium will use a special scan to check the livers of 385 adult patients with diabetes. The goal is to gather information to better understand the link …
Matched conditions: T2D
Phase: NA • Sponsor: Ziekenhuis Oost-Limburg • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC